Skip to main content
Top
Published in: Rheumatology International 6/2012

01-06-2012 | Short Communication

Massive intracerebral hemorrhage associated with Wegener granulomatosis

Authors: Mevlut Ceri, Levent Ortabozkoyun, Selman Unverdi, Mustafa Kirac, Murat Duranay

Published in: Rheumatology International | Issue 6/2012

Login to get access

Abstract

Wegener granulomatosis (WG) is a necrotizing granulomatous vasculitis that predominantly affects airways and kidneys. But central nervous system involvement (7–11%) is an uncommon. Massive ICH may occur in the course of WG, and this serious condition is related with high risk of mortality. Therefore, the new treatment strategies may be considered in addition to classical practices in serious organ involvement and recurrent attack. Here, we present an adult patient with WG whose disease was complicated by a massive intracerebral hemorrhage (ICH), which subsequently led to death.
Literature
1.
go back to reference Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD et al (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498PubMed Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD et al (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498PubMed
2.
go back to reference Memet B, Rudinskaya A, Krebs T, Oelberg D (2005) Wegener granulomatosis with massive intracerebral hemorrhage. J Clin Rheumatol 11:314–318PubMedCrossRef Memet B, Rudinskaya A, Krebs T, Oelberg D (2005) Wegener granulomatosis with massive intracerebral hemorrhage. J Clin Rheumatol 11:314–318PubMedCrossRef
3.
go back to reference Kishimoto M, Arakawa KC (2003) A patient with Wegener granulomatosis and intraventricular hemorrhage. J Clin Rheumatol 9:354–358PubMedCrossRef Kishimoto M, Arakawa KC (2003) A patient with Wegener granulomatosis and intraventricular hemorrhage. J Clin Rheumatol 9:354–358PubMedCrossRef
4.
go back to reference Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L (2006) Central nervous system involvement in Wegener granulomatosis. Medicine (Baltimore) 85:54–65 Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L (2006) Central nervous system involvement in Wegener granulomatosis. Medicine (Baltimore) 85:54–65
5.
go back to reference Zhang W, Zhou G, Shi Q, Zhang X, Zeng XF, Zhang FC (2009) Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides. Clin Exp Rheumatol 27:65–69 Zhang W, Zhou G, Shi Q, Zhang X, Zeng XF, Zhang FC (2009) Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides. Clin Exp Rheumatol 27:65–69
6.
go back to reference Granziera C, Michel P, Rossetti AO, Lurati F, Reymond S, Bogousslavsky J (2005) Wegener granulomatosis presenting with haemorrhagic stroke in a young adult. J Neurol 252:615–616PubMedCrossRef Granziera C, Michel P, Rossetti AO, Lurati F, Reymond S, Bogousslavsky J (2005) Wegener granulomatosis presenting with haemorrhagic stroke in a young adult. J Neurol 252:615–616PubMedCrossRef
Metadata
Title
Massive intracerebral hemorrhage associated with Wegener granulomatosis
Authors
Mevlut Ceri
Levent Ortabozkoyun
Selman Unverdi
Mustafa Kirac
Murat Duranay
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1954-3

Other articles of this Issue 6/2012

Rheumatology International 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.